News Releases

Anixa Biosciences Appoints Leading Researchers in Immuno-Oncology to its Scientific Advisory Board

October 11, 2018

Anixa Biosciences to Present at Artificial Intelligence Conference

October 5, 2018

ITUS Corporation Changing Company Name to Anixa Biosciences and Stock Ticker Symbol to ANIX

September 28, 2018

Moffitt Cancer Center and ITUS Corporation Announce Scheduling of Pre-IND Meeting with the FDA for their CAR-T Therapy

September 5, 2018

ITUS Corporation to Present at Next Generation Dx Summit

August 17, 2018

Moffitt Cancer Center and ITUS Corporation Request Meeting with FDA Regarding Ovarian Cancer CAR-T Therapy

August 1, 2018

ITUS Corporation Releases Results for Cchek™ Breast Cancer Study

July 30, 2018

ITUS Corporation Announces Second Commercial Focus for Cchek™ will be Breast Cancer

July 6, 2018

ITUS to Ring the NASDAQ Closing Bell on July 5th

June 29, 2018

ITUS Accelerates Schedule for its CAR T Therapy and Provides Update

June 26, 2018

Latest News & Events

Aug 12, 2025

Anixa Biosciences Announces Issuance of Additional U.S. Patent for CAR-T Technology

Read More...

Aug 8, 2025

Anixa Biosciences Announces Dr. Robert Wenham will speak about Immunotherapy in surviving Ovarian Cancer at the 13th Annual Ovarcoming Cancer Conference

Read More...

Aug 4, 2025

Anixa Biosciences Announces Commencement of US FDA Approved IND Transfer to Support Upcoming Phase 2 Breast Cancer Vaccine Trial

Read More...